← All news
Markets
Cellectar Biosciences, Inc. (CLRB) Discusses Scientific Rationale and Potential of Phospholipid Ether Platform in Targeted Cancer Therapy - Slideshow
Covered by 1 outlet
All coverage · 2 articles
Seeking Alpha
·Aug 18, 23:11 UTC
Cellectar Biosciences, Inc. (CLRB) Discusses Scientific Rationale and Potential of Phospholipid Ether Platform in Targeted Cancer Therapy Transcript
Seeking Alpha
·Aug 18, 18:32 UTC